Tailoring the size distribution of ultrasound contrast agents: Possible method for improving sensitivity in molecular imaging

Molecular Imaging

Volumn 6, Issue 6, 2007, Pages 384-392

  Talu, Esra ^b   Hettiarachchi, Kanaka ^b   Zhao, Shukui ^b   Powell, Robert L ^b   Lee, Abraham P ^b   Longo, Marjorie L ^b   Dayton, Paul A ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACOUSTIC TESTING; MICROBUBBLE; MOLECULAR IMAGING;

BANDWIDTH; IMAGING SYSTEMS; LIGANDS; MOLECULAR STRUCTURE; NATURAL FREQUENCIES; ULTRASONIC IMAGING;

SIZE DISTRIBUTION;

CONTRAST MEDIUM;

ARTICLE; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; COMPUTER SIMULATION; DIAGNOSTIC PROCEDURE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; ECHOGRAPHY; EVALUATION; HUMAN; METHODOLOGY; MICROBUBBLE; MOLECULAR WEIGHT; PARTICLE SIZE; SENSITIVITY AND SPECIFICITY; STATISTICAL DISTRIBUTION;

CELLS, CULTURED; COMPUTER SIMULATION; CONTRAST MEDIA; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HUMANS; MICROBUBBLES; MOLECULAR DIAGNOSTIC TECHNIQUES; MOLECULAR WEIGHT; PARTICLE SIZE; SENSITIVITY AND SPECIFICITY; STATISTICAL DISTRIBUTIONS; ULTRASONOGRAPHY;

EID: 37649016142     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2007.00034     Document Type: Article

References (35)

1. Lanza GM, Wallace KD, Scott MJ, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996;94:3334-40.
2. Soman NR, Marsh JN, Hughes MS, et al. Acoustic activation of targeted liquid perfluorocarbon nanoparticles does not compromise endothelial integrity. IEEE Trans Nanobioscience 2006;5:69-75.
3. Tiukinhoy-Laing SD, Buchanan K, Parikh D, et al. Fibrin targeting of tissue plasminogen activator-loaded echogenic liposomes. J Drug Target 2007;15:109-14.
4. Leong-Poi H, Christiansen J, Klibanov AL, et al. Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins. Circulation 2003;107:455-60.
5. Rychak JJ, Lindner JR, Ley K, Klibanov AL. Deformable gas-filled microbubbles targeted to P-selectin. J Control Release 2006;114: 288-99.
6. Weiler GE, Wong MK, Modzelewski RA, et al. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res 2005;65:533-9.
7. Klibanov AL, Rychak JJ, Yang WC, et al. Targeted ultrasound contrast agent for molecular imaging of inflammation in highshear flow. Contrast Media MoI Imaging 2006; 1:259-66.
8. Dayton PA, Allen JS, Ferrara KW. The magnitude of radiation force on ultrasound contrast agents. J Acoust Soc Am 2002;112:2183-92.
9. Behm CZ, Lindner JR. Cellular and molecular imaging with targeted contrast ultrasound. Ultrasound Q 2006;22:67-72.
10. Lanza GM, Wickline, SA. Targeted ultrasonic contrast agents for molecular imaging and therapy. Curr Probl Cardiol 2003;28:625-53.
11. Dayton PA, Pearson D, Clark J, et al. Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of {alpha}vlbeta}3-expressing cells. MoI Imaging 2004;3:125.
12. Schumann PA, Christiansen JP, Quigley RM, et al. Targetedmicrobubble binding selectively to GPIIb IHa receptors of platelet thrombi. Invest Radiol 2002;37:587-93.
13. Lindner JR, Dayton PA, Coggins MP, et al. Non-invasive assessment of inflammation using ultrasound detection of phagocytosed microbubbles. Circulation 2000;102:531-8.
14. Ellegala DB, Leong-Poi H, Carpenter JE, et al. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. Circulation 2003;108:336-41.
15. Weiler G, Wong M, Modzelewski RA, et al. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res 2005;65:533-9,
16. Zhao S, Borden M, Bloch SH, et al. Radiation-force assisted targeting facilitates ultrasonic molecular imaging. Mol Imaging 2004;3:135-48.
17. Rychak JJ, Klibanov AL, Ley KF, Hossack JA. Enhanced targeting of ultrasound contrast agents using acoustic radiation force. Ultrasound Med Biol 2007;33:1132-9.
18. Zhao S, Kruse DE, Ferrara KW, Dayton PA. Acoustic response from adherent targeted contrast agents. J Acoust Soc Am 2006; 120: EL63-9.
19. Zhao S, Kruse D, Ferrara K, Dayton PA. Selective imaging of adherent targeted ultrasound contrast agents. Phys Med Biol 2007; 52:2055-72.
20. Hughes MS, Klibanov AL, Marsh JN, et al. Broadband time-domain reflectometry measurement of attenuation and phase velocity in highly attenuating suspensions with application to the ultrasound contrast medium Albunex. J Acoust Soc Am 2000;108:813-20.
21. Ganan-Calvo AM, Gordillo JM. Perfectly monodisperse microbubbling by capillary flow focusing. Phys Rev Lett 2001;87:2745014.
22. Garstecki P, Ganan-Calvo AM, Whitesides GM. Formation of bubbles and droplets in microfluidic systems. Bull Pol Acad Sci Tech Sci 2005;53:361-72.
23. Morgan KE, Allen JS, Dayton PA, et al. Experimental and theoretical evaluation of microbubble behavior: effect of transmitted phase and bubble size. IEEE Trans Ultrason Ferroelectr Freq Control 2000;47:1494-509.
24. Hettiarachchi K, Talu E, Longo ML, et al. On-chip generation of microbubbles as a practical technology for manufacturing contrast agents for ultrasonic imaging. Lab Chip 2007;7:463-8.
25. Talu E, Hettiarachchi K, Nguyen H, et al. Lipid-stabilized monodisperse microbubbles produced by flow focusing for use as ultrasound contrast agents. 2006:1568-1571. DOI 10.1109/ ULTSYM.2006.398.
26. Borden MA, Pu G, Runner GJ, Longo ML. Surface phase behavior and microstructure of lipid/PEG-emulsifier monolayer-coated microbubbles. Colloids Surf B 2004;35:209-23.
27. Klibanov AL, Rasche PT, Hughes MS, et al. Detection of individual microbubbles of ultrasound contrast agents: imaging of freefloating and targeted bubbles. Invest Radiol 2004;39:187-95.
28. Weiler G, Villanueva FS, Tom EM, Wagner WR. Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-I and sialyl Lewisx. Biotechnol Bioeng 2005;92:780-8.
29. Unger EC, McCreery TP, Sweitzer RH, et al. Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Invest Radiol 1998;33:886-92.
30. Bloch SH, Dayton PA, Ferrara KW. Targeted imaging using ultrasound contrast agents. Progess and opportunities for clinical and research applications. IEEE Eng Med Biol Mag 2004;23: 18-29.
31. Talu E, Lozano MM, Powell RL, et al. Long-term stability by lipid coating monodisperse microbubbles formed by a flow-focusing device. Langmuir 2006;22:9487-90.
32. Klibanov AL, Hughes MS, Villanueva FS, et al. Targeting and ultrasound imaging of microbubble-based contrast agents. Magma 1999;8:177-84.
33. Borden MA, Martinez GV, Ricker J, et al. Lateral phase separation in lipid-coated microbubbles. Langmuir 2006;22:4291-7.
34. Villanueva FS, Lu E, Bowry S, et al. Myocardial ischemic memory imaging with molecular echocardiography. Circulation 2007;115: 345-52.
35. Chomas JE, Dayton P, May D, Ferrara K. Threshold of fragmentation for ultrasonic contrast agents. J Biomed Opt 2001; 6:141-50.